| Financial Year |
March 31 2023 |
| Monetary Funds |
1,207,842,900.30 |
| Held-for-trading Financial Assets |
1,438,266,500.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
336,307,643.16 |
| Advances to Suppliers |
67,473,148.52 |
| Other Receivables |
120,729,314.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,028,209.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,217,633,684.27 |
| Other Current Assets |
123,882,191.13 |
| Total Current Assets |
12,023,605,034.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,557,363,668.28 |
| Long-term Equity Investment |
1,932,730,267.80 |
| Investment Properties |
555,082,144.66 |
| Fixed Assetes |
3,958,187,017.20 |
| Under-construction Projects |
1,110,947.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,664,687.25 |
| R&D expenses |
-- |
| Goodwill |
47,589,053.16 |
| Long-Term Deferred and Prepaid Expenses |
4,400,043.44 |
| Deferred Income Tax Assets |
273,781,718.72 |
| Other Non-Current Assets |
248,770,894.32 |
| Sub-Total of Non-Current Assets |
13,802,267,153.13 |
| Total Assets |
25,825,872,187.41 |
| Short-Term Loans |
3,143,153,355.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,000,000.00 |
| Accounts Payable |
235,065,726.85 |
| Accounts Received In Advance |
61,951,068.46 |
| Employee Compensation Payable |
83,569,775.36 |
| Taxes Payable |
297,829,244.67 |
| Interest Payable |
-- |
| Dividend Payable |
1,573,290.02 |
| Other payables |
546,096,720.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,006,510,194.01 |
| Other Current Liabilities |
769,963.54 |
| Sub-Total of Current Liabilities |
7,441,384,078.00 |
| Long-term Loans |
2,918,000,451.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
433,163,339.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,133,031.74 |
| Deferred Income Tax Liabilities |
197,519,992.76 |
| Other Non-Current Liabilities |
1,545,817,830.76 |
| Sub-Total of Non-Current Liabilities |
5,705,949,803.13 |
| Total Liabilities |
13,147,333,881.13 |
| Paid-In Capital(Or Share Stock) |
1,621,922,452.00 |
| Capital Surplus |
4,045,486,667.41 |
| Surplus Reserve |
423,784,133.59 |
| LESS:Treasury Stock |
65,756,319.74 |
| Undistributed Profits |
5,738,774,685.96 |
| Minority Stockholder's Interest |
5,340,410.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,673,197,895.95 |
| Owner's Equity（Stockholder's Equity） |
12,678,538,306.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,825,872,187.41 |
